This study shows that at midyear 2019, more than 6 in 10 (63%) local jail jurisdictions reported that they conducted opioid use disorder (OUD) screenings of persons at intake. Fewer than 2 in 10 (19%) jurisdictions said that they initiated medication-assisted treatment (MAT) for those identified as having OUD.
After intake, nearly a quarter (24%) of jail jurisdictions continued MAT for OUD for persons admitted with a current prescription or for those who were getting services from a methadone clinic prior to admission. More than half (54%) of jail jurisdictions provided confined persons medications?such as clonidine, lofexidine, methadone or buprenorphine (e.g., Suboxone)?to treat opioid withdrawal. Upon the release of individuals from jail facilities, about 28% of local jail jurisdictions linked persons with OUD to MAT in the community. A quarter (25%) of jail jurisdictions provided overdose reversal medications to persons with OUD upon release.
Opioid Use Disorder Screening and Treatment in Local Jails, 2019 (NCJ 305179) was written by BJS Statisticians Laura M. Maruschak, Todd D. Minton, and Zhen Zeng, PhD. The report, related documents, and additional information about BJS?s statistical publications and programs are available on the BJS website at bjs.ojp.gov.
The Bureau of Justice Statistics of the U.S. Department of Justice is the principal federal agency responsible for collecting, analyzing, and disseminating reliable statistics on crime and criminal justice in the United States. Alexis R. Piquero, PhD, is the director.
For more information on BJS's publications, data collections, data analysis tools, and funding opportunities,?visit?bjs.ojp.gov.
|
?
